Kohlberg Kravis Roberts & Co. L.P.
Source: SEC Form 13F · as of Mar 2026Kohlberg Kravis Roberts & Co. L.P. holds 2 biotech & pharma companies tracked by BioSniper, totaling $989.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
2
Total value held
$989.8M
BioSniper AIPage evidence connected
Prepared research question
What matters most for BridgeBio Pharma, Inc. (BBIO)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| BBIOBridgeBio Pharma, Inc. | 13,260,971 | $984.8M |
| CHRSCoherus Oncology, Inc. | 3,036,076 | $5.1M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.